Literature DB >> 34078044

[Expert consensus on clinical practice of RET fusion detection in non-small cell lung cancer in China].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34078044     DOI： 10.3760/cma.j.cn112151-20210411-00273

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN： 0529-5807


× No keyword cloud information.
  2 in total

1.  Pralsetinib for the treatment of a RET-positive advanced non-small-cell lung cancer patient harboring both ANK-RET and CCDC6-RET fusions with coronary heart disease: a case report.

Authors:  Yan Meng; Lulu Li; Huan Wang; Xiaofang Chen; Yali Yue; Meiqing Wang; Lingru Meng; Bafei Li; Xiao Li
Journal:  Ann Transl Med       Date:  2022-04

Review 2.  [Advances in the Treatment of RET Fusion-positive Advanced Non-small Cell Lung Cancer].

Authors:  Qingyun Gao; Junwei Su; Faman Xiao; Xiaocheng Lin; Jinji Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.